Contract Breach Suit Against Bausch Persists Under Judge’s Order

A generic drug developer sufficiently alleged that the multinational pharmaceutical company Bausch Health breached its duty of good faith and fair dealing in agreements to help develop two generic ophthalmic drugs, a federal judge ruled.

Judge Sara L. Ellis of the US District Court for the Northern District of Illinois on Monday denied in part Bausch’s motion to dismiss a November 2023 lawsuit from Chandra V. Pharmaceutical Consultants LLC over deals between the two companies to develop, obtain Food and Drug Administration approval for, manufacture, and commercialize Tobramycin Ophthalmic Ointment for eye infections and Prednisolone Acetate Ophthalmic Ointment for the ...